To conduct survey of safety of Gadolinium-based substance used to improve the visibility of internal body structures in Magnetic Resonance Imaging (MRI) in India
Not Applicable
- Conditions
- Health Condition 1: R948- Abnormal results of function studies of other organs and systems
- Registration Number
- CTRI/2024/04/066403
- Lead Sponsor
- Bayer Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. GBCA-naïve male or female patients of at least 18 years of age
2. willing to participate in the active surveillance and agree to be contacted by phone after 6 (±2)
weeks after the MR scan for brief interviews
Exclusion Criteria
There is no specific exclusion criteria.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method